Anti-MerTK ANTIBODIES AND USES THEREOF
AssigneesConcept To Medicine Biotech Co., Ltd., Lepu Biopharma Co., Ltd.
InventorsWenci GONG, Zhijian CAI, Qi WU, Feifei CUI, Lei FANG
Life of this patent
Estimating the term…
Abstract
This disclosure provides anti-MerTK antibodies, variants thereof and humanized versions. The newly disclosed antibodies exhibited high affinity to the MerTK protein and can be used to treat cancers, in particular solid tumors.
Claims25
An antibody or antigen-binding fragment thereof which has specificity to the human Mer proto-oncogene tyrosine-protein kinase (MerTK) protein and comprises a heavy chain variable region (VH) comprising a VH CDR1, a VH CDR2 and a VH CDR3, and a light chain variable region (VL) comprising a VL CDR1, a VL CDR2, and a VL CDR3, wherein the VH CDR1, VH CDR2, VH CDR3, VL CDR1, VL CDR2 and VL CDR3 comprise, respectively, the amino acid sequences of
- SEQ ID NO:
- 25-30;
- SEQ ID NO:
- 59-64;
- SEQ ID NO:
- 65-70;
- SEQ ID NO:
- 31-33, 28-29, 34;
- SEQ ID NO:
- 35-40;
- SEQ ID NO:
- 41-46;
- SEQ ID NO:
- 47-52;
- SEQ ID NO:
- 53-58;
- SEQ ID NO:
- 71, 66, 72, 73, 69, 74;
- SEQ ID NO:
- 65, 75, 67, 76, 69, 77;
- SEQ ID NO:
- 71, 78-79, 73, 69, 74;
- or
- SEQ ID NO:
- 65-66, 80-81, 69-70.
(canceled)
18-19. (canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.